medigraphic.com
ISSN 2594-1526 (Electronic)
Antes Revista del Instituto Nacional de Enfermedades Respiratorias

 Ver anteriores al 2010

2002, Number 2

<< Back Next >>

Neumol Cir Torax 2002; 61 (2)

Results obtained at twelve years from the Program to Stop Smoking of a cognitive-behavioral and pharmacological support therapy

Medina-Morales F, Echegoyen-Carmona R, Medina-Zarco LE, Galicia-Tapia J

Language: Spanish
References: 15
Page: 27-30
PDF size: 54.31 Kb.


ABSTRACT

Clinical records of patients with lung cancer attending a third-level hospital (Centro Hospitalario 20 de Noviembre, ISSSTE, Mexico City) from 1995 to 1999 were reviewed. More than half patients had between 51 and 71 years old. Although men predominated almost 2.5 fold than women in advanced ages, this proportion decreased with younger age, and was similar in both genders among youngest patients. The proportion of smokers in each gender followed this same trend. Symptoms that predominated were malaise, dyspnea and chest pain, and the location of the tumor predominated in upper lobes. Major histological types were adenocarcinoma (60.1%), epidermoid (26.2%) and small cell (13.7%). Although the former two types similarly occurred in smokers and nonsmokers, the small cell carcinoma predominated among nonsmokers.


REFERENCES

  1. Parkin DM. Trends in lung cancer incidence worldwide. Chest 1989; 96: 5S-7S.

  2. Stanley K, Stjernsward J. Lung Cancer. A worldwide health problem. Chest 1989; 96: 1S-5S.

  3. Frank AL. Epidemiology and etiology of lung cancer. Clin Chest Med 1982; 3: 219-228.

  4. Beckett WS. Epidemiology and etiology of Lung Cancer. Clin Chest Med 1993; 14: 1-15.

  5. Miller AB, Harve AR. Diet and lung cancer. Vitamin A and B carotens. Chest 1989; 96: 8S-9S.

  6. Mohar BA, Frías MM. Epidemiología del cáncer broncogénico en México. Neumol Cir Tórax 1993; 52: 19-30.

  7. Flores-Barroeta F, Velazco-Aviles F. Principales padecimientos encontrados en las necropsias de algunos hospitales de la Ciudad de México. Gac Med Méx 1971; 102: 208-215.

  8. Medina F, Barrera R, Morales J, Echegoyen R, Chavarría J, Rébora F. Primary lung cancer in Mexico City: a report of 1019 cases. Lung Cancer 1996; 14: 185-193.

  9. Harkness EF, Brewster DH, Kerr KM, Fergusson RJ, MacFarlane GJ. Changing trends in incidence of lung cancer by histologic type in Scotland. Int J Cancer 2002; 102: 179-183.

  10. Brennan P, Bray I. Recent trends and future directions for lung cancer mortality in Europe. Br J Cancer 2002; 87: 43-48

  11. Pandey M, Mathew A, Nair MK. Global perspective of tobacco habits and lung cancer: a lesson for third world countries. Eur J Cancer Prev 1999; 8:271-279

  12. Sepúlveda J. La epidemia del tabaquismo en las Américas. Salud Pública Mex 2002; 44: S7-S10.

  13. Beckles MA, Spiro SG, Colice GL, Rudd RM. Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes. Chest 2003; 123: 97S-104S

  14. Vicent RG, Pickren JW, Lane WW, Bross Y, Takita H, Houten L et al. The changing histopathology of lung cancer. A review of 1682 cases. Cancer 1977; 39: 1647-1655.

  15. Patz EF Jr. Imaging bronchogenic carcinoma. Chest 2000; 117: 90S-95S.




2020     |     www.medigraphic.com